Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer.
Saved in:
| Title: | Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer. |
|---|---|
| Authors: | Lee, Ye Jin1 (AUTHOR), Park, Young Sik1 (AUTHOR), Lee, Hyun Woo2 (AUTHOR), Park, Tae Yoen2 (AUTHOR), Lee, Jung Kyu2 (AUTHOR), Heo, Eun Young2 (AUTHOR) eunyoungheo@gmail.com |
| Source: | Scientific Reports. 1/12/2022, Vol. 12 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-021-04630-9 |